Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Access to Medicine Index

Merck KGaA, Darmstadt, Germany ranks 4th in 2016 Access to Medicine Index

Merck KGaA, Darmstadt, Germany ranks 4th in 2016 Access to Medicine Index

Merck KGaA, Darmstadt, Germany ranks fourth in the 2016 Access to Medicine (ATM) Index, one of the three most credible sustainability ratings worldwide, advancing two more ranks since the 2014 Index. Every two years, the Access to Medicine Foundation, through its Index, benchmarks the top pharmaceutical companies with respect to their efforts to advance global access to medicines.
Belen Garijo
Belen Garijo, member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO of the healthcare business.
“Our outstanding performance in the 2016 ATM Index underlines our commitment to help people in low- and middle-income countries that lack access to affordable healthcare. Access to Health has become a strategic priority for us and we are very pleased that our efforts have been recognized by the ATM Foundation. We have made outstanding progress in the last five years and we remain committed to sustainably deliver healthcare solutions to help the two billion people worldwide, who still lack access to effective and affordable healthcare.”
 
Merck KGaA, Darmstadt, Germany has been recognized for its access-related targets that align with the United Nations Sustainable Development Goals (SDGs), for its leadership in capacity-building and for having one of the most transparent approaches to Intellectual Property (IP) management. Furthermore, Merck KGaA, Darmstadt, Germany engages in various R&D partnerships and files to register a high proportion of its newest products in high-burden countries.
Merck KGaA, Darmstadt, Germany’s improved ATM ranking reflects the company’s overarching commitment to improving sustainable access to high quality solutions for underserved populations and communities, regardless of their geographic location or ability to pay.

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.